28277316|t|CXCL14 - CXCR4 and CXCL12 - CXCR4 Axes May Play Important Roles in the Unique Invasion Process of Endometrioid Carcinoma With MELF-Pattern Myoinvasion
28277316|a|The term " MELF-pattern myometrial invasion " (MELF pattern) denotes an unusual morphology of myometrial invasion in endometrioid carcinomas, and is associated with frequent lymphovascular invasion and lymph node metastasis. In this study, tumor cells were directly collected from a MELF pattern site, using laser microdissection. Comprehensive microarray analysis of the genes was conducted, and based on the results, expression of a metastasis progression gene, CXCR4, and its ligands CXCL14 and CXCL12, was further investigated. In vitro studies of endometrioid carcinoma cell lines revealed elevated invasion activity in a manner dependent on the CXCL14 - CXCR4 or CXCL12 - CXCR4 axis. Immunohistochemical analysis of 93 (MELF group, 46; non-MELF group, 47) cases illustrated CXCR4 was expressed in all endometrioid carcinomas, while based on CXCL14 and CXCL12 expression score, high proportions of cells were positive at the sites of the MELF pattern (P<0.01). There was no significant difference in progression-free survival or overall survival between MELF group and non-MELF group by Kaplan-Meier analysis. These findings suggest a possibility that cells at the sites of MELF pattern had acquired increased invasiveness through the function of the CXCL14 - CXCR4 and CXCL12 - CXCR4 axes.
28277316	0	6	CXCL14	T103	UMLS:C1335988
28277316	9	14	CXCR4	T103	UMLS:C2352110
28277316	19	25	CXCL12	T103	UMLS:C1528383
28277316	28	33	CXCR4	T103	UMLS:C2352110
28277316	78	86	Invasion	T033	UMLS:C1269955
28277316	98	120	Endometrioid Carcinoma	T038	UMLS:C0206687
28277316	126	138	MELF-Pattern	T082	UMLS:C0449774
28277316	139	150	Myoinvasion	T033	UMLS:C1269955
28277316	162	174	MELF-pattern	T082	UMLS:C0449774
28277316	175	185	myometrial	T082	UMLS:C0521387
28277316	186	194	invasion	T033	UMLS:C1269955
28277316	198	210	MELF pattern	T082	UMLS:C0449774
28277316	245	255	myometrial	T082	UMLS:C0521387
28277316	256	264	invasion	T033	UMLS:C1269955
28277316	268	291	endometrioid carcinomas	T038	UMLS:C0206687
28277316	325	348	lymphovascular invasion	T033	UMLS:C1708790
28277316	353	374	lymph node metastasis	T038	UMLS:C0024232
28277316	391	402	tumor cells	T017	UMLS:C0334227
28277316	434	446	MELF pattern	T082	UMLS:C0449774
28277316	459	480	laser microdissection	T058	UMLS:C1113652
28277316	496	515	microarray analysis	T058	UMLS:C1449575
28277316	523	528	genes	T017	UMLS:C0017337
28277316	570	580	expression	T038	UMLS:C1171362
28277316	586	620	metastasis progression gene, CXCR4	T103	UMLS:C2352110
28277316	630	637	ligands	T038	UMLS:C1749457
28277316	638	644	CXCL14	T103	UMLS:C1335988
28277316	649	655	CXCL12	T103	UMLS:C1528383
28277316	703	725	endometrioid carcinoma	T038	UMLS:C0206687
28277316	726	736	cell lines	T017	UMLS:C0085983
28277316	755	763	invasion	T033	UMLS:C1269955
28277316	802	808	CXCL14	T103	UMLS:C1335988
28277316	811	816	CXCR4	T103	UMLS:C2352110
28277316	820	826	CXCL12	T103	UMLS:C1528383
28277316	829	834	CXCR4	T103	UMLS:C2352110
28277316	931	936	CXCR4	T103	UMLS:C2352110
28277316	941	950	expressed	T038	UMLS:C1171362
28277316	958	981	endometrioid carcinomas	T038	UMLS:C0206687
28277316	998	1004	CXCL14	T103	UMLS:C1335988
28277316	1009	1015	CXCL12	T103	UMLS:C1528383
28277316	1016	1026	expression	T038	UMLS:C1171362
28277316	1054	1059	cells	T017	UMLS:C0007634
28277316	1065	1073	positive	T033	UMLS:C1446409
28277316	1081	1086	sites	T082	UMLS:C0205145
28277316	1094	1106	MELF pattern	T082	UMLS:C0449774
28277316	1127	1152	no significant difference	T033	UMLS:C0243095
28277316	1308	1313	cells	T017	UMLS:C0007634
28277316	1321	1326	sites	T082	UMLS:C0205145
28277316	1330	1342	MELF pattern	T082	UMLS:C0449774
28277316	1366	1378	invasiveness	T038	UMLS:C0027626
28277316	1391	1399	function	T038	UMLS:C0031843
28277316	1407	1413	CXCL14	T103	UMLS:C1335988
28277316	1416	1421	CXCR4	T103	UMLS:C2352110
28277316	1426	1432	CXCL12	T103	UMLS:C1528383
28277316	1435	1440	CXCR4	T103	UMLS:C2352110